Treatment Frequency and Satisfaction in Patients With Advanced Prostate Cancer

Completed

• Conditions: Prostatic Neoplasms

• Registration Number: NCT01441713
• Lead Sponsor: Copenhagen University Hospital at Herlev

Brief Summary

Patients with advanced prostate cancer usually receive some kind of pharmaceutical castration or undergo surgical castration. At the investigators department the pharmaceutical treatment is most often given with a 3 month interval.

Over the last few years new drugs, which allow for lees frequent treatment, have been developed. The purpose of this study is to assess how the treatment affects patients and if our current patients would prefer to receive treatment at different intervals than they do at the present time. At the same time the investigators will assess how surgical treatment affects our patients. This will be assessed by patient questionnaires administered at our clinic.

Detailed Description

Not available

Study Timeline

• Study Start: 2011-09
• Study First Submitted: 2011-09-09
• Study First Submitted QC: 2011-09-27
• Study First Posted: 2011-09-28
• Primary Completion: 2012-05
• Study Completion: 2012-06
• Status Verified: 2012-12
• Last Update Submitted: 2012-12-04
• Last Update Posted: 2012-12-05

Recruitment & Eligibility

• Status: COMPLETED
• Sex: Male
• Target Recruitment: 178

Inclusion Criteria

• A diagnosis of advanced prostate cancer
• Receiving hormone manipulation treatment (pharmaceutical castration) OR having undergone surgical castration (orchiectomy)

Exclusion Criteria

• Inability to read/write Danish

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Preferred treatment/control frequency for patients with advanced prostate cancer	Up to 1 year	Preferred treatment frequency is assessed by patient answers to the question: "If treatments were equally effective from a medical standpoint - How often would you then prefer to receive treatment"

Secondary Outcome Measures

Name	Time	Method
Treatment satisfaction	Up to 1 year	Treatment satisfaction ranging from "Very satisfied" til "Very unsatisfied" assessed by patient answers to the questionnaire
Side effects to treatment	Up to 1 year	Side effects to treatment assessed by patient answers to the questionnaire
Treatment satisfaction, preferred frequency of clinical control, and side effects after surgical castration	Up to 1 year	As a secondary endpoint the investigators will look at answers to satisfaction, wishes for control visits and side effects in the group of patients who received surgical castration for their advanced prostate cancer.

Trial Locations

Locations (1)

Department of urology, Herlev Hospital; 🇩🇰 Herlev, Denmark